首页> 外文OA文献 >Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration : a pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)

【2h】

Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration : a pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)

机译：持续时间超过6个月的MDS后预后不良的骨髓增生异常（MDS）和继发性急性髓性白血病（sAML）的强化化疗：欧洲癌症研究与治疗组织（EORTC-LCG）白血病合作小组的一项初步研究

页面导航

著录项
相似文献
相关主题

著录项

作者
Witte T.J.M. de; Suciu S.; Peetermans M.; Fenaux P.; Strijckmans P.; Hayat M.; Jaksic B.; Selleslag S.; Zittoun R.; Dardenne M.; Solbu G.; Zwierzina H.; Muus P.;
展开▼
作者单位

展开▼
年度 1995
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabine. [J] . Ruutu T, Hanninen A, Jarventie G, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 1997,第2期

机译：加用伊达比星和阿糖胞苷对预后不良的骨髓增生异常综合症（MDS）和急性髓细胞性白血病的强化化疗。
2. Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group. [J] . Lubbert M, Suciu S, Baila L, Journal of Clinical Oncology . 2011,第15期

机译：低剂量地西他滨与老年患者（不适合进行密集化学疗法的中度或高危性骨髓增生异常综合症（MDS）的老年患者的最佳支持治疗）：欧洲癌症白血病研究和治疗组织和癌症治疗组织的随机III期研究的最终结果德国MDS研究小组。
3. The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921) [J] . M Oosterveld, S Suciu, G Verhoef, Leukemia . 2003,第5期

机译：与HLA相同的同胞供体的存在不会对高危MDS或继发AML的继发性AML（sAML）患者进行强化化疗并随后进行移植的结果产生影响：EORTC，EBMT，SAKK和GIMEMA白血病的前瞻性研究团体（EORTC研究06921）
4. A Metadata-Based Patient Register for Cooperative Clinical Research: A Case Study in Acute Myeloid Leukemia [C] . Anja S. FISCHER, Ulrich MANSMANN Medical Informatics in Europe Conference. . 2011

机译：基于元数据的合作临床研究患者注册：急性髓性白血病案例研究
5. Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA) Leukemia Cooperative Groups [O] . Marysia Hengeveld, Stefan Suciu, Matthias Karrasch, -1

机译：对于年龄在46至60岁之间的成人急性髓性白血病强化巩固治疗与标准巩固和维持治疗相比：欧洲癌症研究与治疗组织（EORTC）的随机III期研究（AML 8B）和Gruppo Italiano Malattie Ematologiche Maligne dellAdulto（GIMEMA）白血病合作小组
6. Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON) [O] . Lowenberg B., Suciu S., Archimbaud E., 1997

机译：重组粒细胞巨噬细胞集落刺激因子在61岁及以上急性髓样白血病（AML）患者缓解诱导化疗期间和之后的应用：AML-11的最终报告，这是欧洲白血病合作小组进行的一项III期随机研究癌症研究和治疗组织（EORTC-LCG）和荷兰比利时血液肿瘤合作组（HOVON）
7. Chemotherapy in a Transplantable Myeloid Leukemia in Brown Norway Rats: Studies on BNML as a Model for Human Acute Myeloid Leukemia [R] . Golly, L. P. 1980

机译：Brown Norway大鼠可移植骨髓性白血病的化疗：BNmL作为人类急性髓性白血病模型的研究

Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration : a pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)

著录项

相似文献

相关主题

期刊订阅